61 – 70 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
CMR feature tracking in cardiac asymptomatic systemic sclerosis : Clinical implications
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
- Contribution to journal › Article
- 2018
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
- Contribution to journal › Article
-
Mark
Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis : A magnetic resonance study
- Contribution to journal › Article
-
Mark
Common measure of quality of life for people with systemic sclerosis across seven European countries : A cross-sectional study
- Contribution to journal › Article
-
Mark
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort
- Contribution to journal › Article
-
Mark
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
- Contribution to journal › Article
- 2017
-
Mark
Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
- Contribution to journal › Article
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
- Contribution to journal › Article
-
Mark
Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis : Analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening
- Contribution to journal › Article
